“In some of the cases, physicians write risk stratification not according to the NCCN guidelines because the treatment is the same for high/very high cases,” Dr Ayub said. Systems that are now ...

During a live event, Richard F. Riedel, MD, discussed Desmoid Tumor Working Group and NCCN guidelines for treating patients with desmoid tumors. Richard F. Riedel, MD: The Desmoid Tumor Working Group ...

The summit will provide perspectives from patients, advocates, providers, payers, and other experts on the role of primary care practitioners in cancer prevention, treatment, and survivorship.

Targeted Oncology: What are some recommendations the NCCN guidelines make about the different lines of therapy for a patient such as this with HR-positive metastatic breast cancer? Megan Kruse, MD: ...

The Generative AI Research & Development (R&D) Center was commissioned earlier to study and suggest appropriate codes and guidelines on the accuracy, responsibility and information security in ...

Immunotherapy is the use of medicines that help a person’s own immune system find and destroy cancer cells. It can be used to treat some people with liver cancer. An important part of the immune ...

Researchers at The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center found socially vulnerable patients with metastatic pancreatic cancer were significantly less likely ...

7. RBI also proposed to review guidelines for lending against gold jewellery. Sanjay Malhotra said, “Loans against the collateral of gold jewellery and ornaments, commonly known as gold loans ...

The Karnataka School Examination and Assessment Board (KSEAB) has released the official Exam 2 timetable for 2nd PUC students, offering a much-awaited second chance for those aiming to improve their ...

“We found that while adherence to NCCN Guidelines improved over time, there remain significant disparities in the receipt of guideline-concordant care among patients with metastatic pancreatic ...

Disparities in mPDAC care quality and outcomes are linked to race and socioeconomic status, affecting cancer-specific survival. Socially vulnerable and minority patients are less likely to receive ...